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Abstract. Angiotensin II (Ang II) stimulates expres- 
sion of tyrosine hydroxylase and norepinephrine trans- 
porter genes in brain neurons; however, the signal- 
transduction mechanism is not clearly defined. This 
study was conducted to determine the involvement of 
the mitogen-activated protein (MAP) kinase signaling 
pathway in Ang II stimulation of these genes. MAP ki- 
nase was localized in the perinuclear region of the neu- 
ronal soma. Ang II caused activation of MAP kinase 
and its subsequent translocation from the cytoplasmic 
to nuclear compartment, both effects being mediated 
by AT1 receptor subtype. Ang II also stimulated SRE- 
and APrbinding activities and fos gene expression and 
its translocation in a MAP kinase-dependent process. 
These observations are the first demonstration of a 
downstream signaling pathway involving MAP kinase 
in Ang II-mediated neuromodulation in noradrenergic 
neurons. 
B 
RAIN angiotensin II (Ang II)  1 plays a key role in the 
central control of blood pressure (BP). This action 
is initiated by the interaction of Ang II with the 
ATi receptor subtypes that are localized on the neurons of 
the cardioregulation-relevant  areas of the brain (Saavedra, 
1992; Steckelings  et al.,  1992; Timmermans et al.,  1993; 
Raizada et al.,  1994; Wright et al.,  1994). Physiological 
mechanisms of Ang II-mediated BP control involve stim- 
ulation of vasopressin  release, stimulation of sympathetic 
pathways involving catecholamines (CA), and dampening 
of the baroreceptor reflex (Saavedra,  1992; Steckelings et 
al., 1992; Timmermans et al., 1993; Raizada et al., 1994; 
Wright and Harding, 1994). The importance of the brain 
Ang II and neuronal AT1 receptors in the control of BP is 
further supported by studies with the spontaneously hy- 
pertensive (SH) rat, a genetic model for human essential 
hypertension. They demonstrate that the SH rat expresses 
a hyperactive brain Ang II system as a result of increased 
levels  of  Ang  II  and  AT1  receptors  (Raizada  et  al., 
1993a,b, 1994). Interruption in this system's hyperactivity 
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porter;  RT-PCR,  reverse  transcriptase-polymerase chain  reaction; SH, 
spontaneously hypertensive; SRE, serum response element; TH, tyrosine 
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results in the normalization of BP, further confirming the 
involvement of this hormonal system in the development 
and establishment of hypertension and high BP in the SH 
rat model (Raizada et al., 1994). 
In spite  of excellent  physiological  studies defining the 
involvement of CA and vasopressin  in Ang II-mediated 
control of BP, relatively little is known about the cellular 
and molecular bases  of these  actions  of Ang II in the 
brain.  For example, it has been shown that Ang II stimu- 
lates turnover of brain CA by interacting with AT  1 recep- 
tor subtypes (Raizada et al., 1994; Sumners et al., 1985, 
1987; Sumners and Raizada,  1986); however,  the  signal 
transduction events associated with this turnover, synthe- 
sis, and uptake of CA remain to be defined (Sumners et al., 
1985, 1987; Sumners and Raizada, 1986). This lack of in- 
formation could be due in part to the inherent complexity 
of the brain, which contains multiple cell types, each with 
its own unique properties, and in part to the presence of 
discrete anatomical and physiological aspects of the brain. 
We  have  developed neuronal cells  in  primary cultures 
from  the  hypothalamus-brainstem areas  of  1-d-old  rat 
brain to circumvent some of these problems and have used 
this in vitro system as a model to investigate the cellular 
and molecular mechanisms of Ang II actions (Raizada et al., 
1994; Sumners and Raizada, 1993; Sumners et al., 1995). 
These studies have demonstrated that Ang II stimulation 
of neuromodulation observed in vivo could be equated to 
its  in  vitro  stimulation  of  norepinephrine  transporter 
(NET), tyrosine hydroxylase (TH), and dopamine 13-hydrox- 
ylase at both the transcriptional and posttranscriptional 
levels (Lu et al., 1996; Yu et al., 1996). The regulation of 
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the AT1 receptor with Ras that initiates a cascade of sig- 
naling events involving the activation of Raf-1  and MAP 
kinase (Yang et al., 1996). Thus, our studies have indicated 
that the  activation  of MAP  kinase  appears  to be  a  key 
event in the signaling mechanism of AT1 receptor-medi- 
ated neuromodulation. 
The  objective  in this study was  to further  our under- 
standing of the sequence of cellular events leading to neu- 
romodulation  by  characterizing  the  signal  transduction 
steps downstream of the activation of MAP kinase.  This 
information would be crucial in elucidating how MAP ki- 
nase  is involved in the transfer  of neuromodulatory sig- 
nals, initiated at the plasma membrane by AT1 receptors 
from cytoplasmic compartment to the nucleus. The obser- 
vations demonstrate  that MAP kinase  is primarily  local- 
ized around the nuclear membrane and that activation by 
Ang II  results  in its translocation into the nucleus. This 
translocation is associated with increases  in SRE-binding 
activities, c-fos gene expression, and in APl-binding activ- 
ity. These increases would potentially stimulate the tran- 
scription of the NET and TH genes. 
Materials and Methods 
Materials 
1-d-old WKY rats were obtained from our breeding colony, which origi- 
nated from Harlan Sprague-Dawley (Indianapolis, IN). DME, plasma- 
derived  horse  serum,  and  1×  crystalline  trypsin  (10,000  BAEE/mg) 
were obtained from Central Biomedia (Irwin, MO). Ang II and mon- 
oclonal anti-TH  antibody were purchased from Sigma Chemical Co. 
(St.  Louis,  MO).  Losartan  potassium  was  a  gift  from  DuPont/Merck 
(Wilmington, DE), and PD123319  was from Res. Biochems., Inc. (Na- 
tick, MA). [~-32p]ATP (3,000  Ci/mmol) and chemiluminescence assay 
reagents were from DuPont/NEN  (Boston, MA).  Reverse transcrip- 
tase-polymerase chain  reaction  (RT-PCR)  Kit was  purchased  from 
Perkin Elmer Cetus (Norwalk, CT),  and DYNAL beads and other re- 
agents  for  poly(A+)RNA  isolation  were  from  DYNAL,  Inc.  (Lake 
Success, NY).  Polyclonal anti-Fos and  anti-AT1 receptor antibodies, 
horseradish  peroxidase-conjugated anti-rabbit  antibody,  and  oligonu- 
cleotides of  SRE  and  AP1  consensus sequences (described  below) 
were  obtained  from  Santa  Cruz  Biotechnology  (Santa  Cruz,  CA). 
Polyclonal anti-MAP kinase  rabbit  antibody and  its agarose  conju- 
gates were from Upstate Biotechnology Inc. (Lake Placid, NY). This 
antibody  recognized  both  nonphosphorylated  and  phosphorylated 
p42 and p44 MAP kinase subtypes. Monoclonal anti-AT1 receptor an- 
tibody was a  gift from Dr.  G.P. Vinson (Queen Mary and Westfield 
College,  London,  UK)  (Vinson et  al.,  1995),  and  monoclonal  anti- 
neurofilament antibody was provided by Dr. J. Shaw (Department 
of Neuroscience University of Florida,  Gainesville, FL).  Polyclonal 
rhodamine-conjugated  anti-rabbit  IgG  Fab  fragment  and  poly- 
clonal  FITC-conjugated  anti-mouse  IgG  Fab  fragment  were  pur- 
chased  from  Boehringer  Mannheim  (Indianapolis,  IN).  Gel-shift 
Assay Kit was purchased from Promega Corp. (Madison, WI). All 
other  biochemicals were  from  Fisher  Scientific  (Pittsburgh,  PA) 
and  were  of  analytical  and  molecular  biology  grades.  Primers  for 
c-fos, TH,  NET,  and MAP kinase sense and antisense oligonuele- 
otide (SON and AON) were synthesized in the DNA synthesis facil- 
ity  of  the  Interdisciplinary  Center  for  Biotechnology  Research, 
University  of Florida.  The  sequences  of these  primers  are  as 
follows:  (TH)  sense:  5'-GGGATGGGAATGCTGTTCTCAAC-3'; 
antisense:  5'-CGAGAGGCATAGTTCCTGAGCTI'-3';  (NET)  sense: 
5'-CCGCATCCATGC'ITCTGGCGCGGATGAA-3';  antisense:  5'- 
GGGCAGGCTCAGATGGCCCAGCCAGTGqT-3';  (MAP  kinase) 
sense oligonucleotide: 5'-CGACTTGCTATCAAGAAAATC-3';  an- 
tisense  oligonucleotide:  5'-GAqTrTCTTGATAGCAACTCG-3'; 
5  3  (SRE  consensus)  , OGATGTCCATATTAGGACATCT  ,  (AP1  consensus) 
-CCTACAGGTATAATCCTGTAGA  - 
5t- CGC'FTGATGAGTCAGCCG  GAA  t 
GCGAACTACTCAGTCGCCTT  -3  . 
Methods 
Prepamtion of  Neumnal Cultures from WKY  Rat Bmins. Neuronal  cultures 
were prepared essentially as described previously (Raizada et al., 1984, 
1993a). Briefly, hypothalamus-brainstem of 1-d-old Wistar-Kyoto normo- 
tensive rat brains, which contained the paraventricnlar nucleus, the su- 
praoptic, anterior, lateral, posterior, dorsomedial and ventromedial nu- 
clei, the medullar obtongata, and the pons, were dissected and brain ceils 
were dissociated by trypsin. Cells were plated on poly-L-lysine precoated 
tissue culture dishes in DME containing 10%  plasma-derived horse se- 
rum. Culture dishes of 35-mm diam (3 x  106 ceils) or 100-ram diam (2 × 
107 cells) were prepared for experiments. Cultures were treated with 1% 
cytosine arabinoside for 3 d followed by establishment of cultures for 10 d 
before their use in the experiments. These cultures have been shown to 
contain 90-95% neuronal cells and 5-10% astrogliai cells (Raizada et al., 
1984, 1993a, 1994). 
Measurement  of  MAP Kinase Activity by ln.Gel Assay. MAP kinase  ac- 
tivity was measured essentially as described elsewhere (Sadoshima et al., 
1995; Yang et al., 1996).  Briefly, neuronal ceils grown in 35-mm culture 
dishes were rinsed three times with ice-cold PBS, pH 7.4, and lysed by 
incubation with 0.5 ml of lysis buffer (25  mM Tris-HCl, 25 mM NaC1, 
1% Triton X-100, 1% deoxycholic acid, 0.1% SDS, 1 mM sodium ortho- 
vanadate, 10 mM sodium fluoride, 10 mM sodium pyrophosphate, 0.5 mM 
EGTA,  1 mM phenylmethylsulfonyl fluoride, 10 p.g/ml  aprotinin, and 
0.8  i~g/ml leupeptin) for 10 min at 4°C.  Lysates from triplicate culture 
dishes were pooled and incubated with 10 I~g of agarose-conjugated anti- 
MAP kinase  antibody at 4"C overnight. Immunoprecipitates were col- 
lected by centrifugation and electrophoresed on 10%  SDS-PAGE con- 
taining 0.5 mg/ml myelin basic protein. The gel was then washed twice in 
20% 2-propanol, 50 mM Tris-HCl, pH 8.0, and twice in 50 mM Tris-HCl, 
pH 8.0, containing 5 mM 2-mercaptoethanol. Each wash lasted for 1 h at 
room temperature with gentle shaking. MAP kinase activity was measured 
by incubating the gel with 40 mM Hepes, pH 8.0, 2 mM DTT,  10 mM 
MgCI2, 0.5 mM EGTA, 40 p.M ATP, and 10 p,  Ci [7-32p]ATP  (3,000  Ci/ 
raM) for 30 min at room temperature, followed by autoradiography as de- 
scribed previously (Yang et al., 1996). 
Immunofluorescence  Staining of  MAP Kinase. Neuronal, astroglial, and 
vascular smooth muscle cells established in 35-ram culture dishes were 
washed twice in PBS, pH 7.4, and fixed in neutral-buffered 1% formalin 
for I h at 4°C. After three rinses in PBS, pH 7.4, cells were permarized by 
incubation with methanol at -20°C for 2 min, incubated with 10% FBS 
for 1 h  at 37°C to suppress nonspeciflc binding, followed by incubation 
with anti-MAP kinase antibody at 5 p~g/ml in a PBS-BSA solution (Ix 
PBS, 0.8% BSA), for 16 h at 4°C. Excess primary antibody was removed 
by washing with PBS,  pH  7.4,  followed by incubation  with  10  I~g/ml 
rhodamine-conjugated anti-rabbit IgG Fab-fragments prepared in PBS- 
BSA solution for 1 h at 37°C. Cells were washed free of unbound second 
antibody by incubating them with PBS, pH 7.4, for 5 rain with gentle shak- 
ing. They were coverslipped and subjected to confocal microscopic analy- 
sis (Lu et al., 1996). 
Double  Immunofluorescence  Staining for MAP Kinase and Neurofila- 
ments. Neuronal cells were stained first with anti-MAP kinase antibody as 
described above. This was followed by staining the cultures for neuroflla- 
ments by incubation with mouse monoclonal antineurofilament antibody 
at a concentration of 5 p,g protein/ml for 1 h at 37°C as described previ- 
ously (Lu et al., 1996). FITC-conjugated anti-mouse IgG Fab-fragment in 
PBS-BSA solution was used as second antibody. Cells were washed six 
times each with PBS, pH 7.4, coversllpped, and analyzed by confocal mi- 
croscopy essentially as described previously (Lu et al., 1996). 
Preparation  of Cytoplasmic  and Nuclear Extracts from Neuronal Cul- 
tures. Neuronal cultures that had been established in 100-mm-diam cul- 
ture dishes were rinsed twice with PBS, pH 7.4, and cells were collected by 
scraping the monolayer with the help of a teflon scraper. Nuclear and cy- 
toplasmic extracts were prepared essentially as described elsewhere with 
minor modification (Abmayr and Workman, 1992). Briefly, the cell pellet 
was incubated in a solution containing 10 mM KC1,1.5 mM MgCI2, 10 mM 
Hepes, 0.5 mM DTT, and 0.2 mM PMSF, pH 7.0, for 10 min at 4°C, fol- 
lowed by homogenization with 15 gentle strokes using a type-B pestle in a 
Dounce homogenizer. The lysis of >90% neurons was determined by mi- 
croscopic examination. The cytoplasmic extract was collected by centrifu- 
gation of the homogenate at 3,300 g for 15 min, and the remaining nuclear 
pellet was lysed by nuclear lysis buffer (20 mM Hepes, pH 7.9, 25% glyc- 
erol, 1.5 mM MgCIz, 0.2 mM EDTA, 0.2 mM PMSF, 0.5 mM DTT, and 
30 mM KCI). The nuclear extract was collected by centrifugation at 25,000 g 
for 30 min at 4°C. Both cytoplasmic and nuclear extracts were dialyzed 
overnight against Ix gel-shift assay buffer (20% glycerol, 5 mM MgCI2, 
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Protein concentrations of the extracts were determined using a Bradford 
protein assay (BioRad Labs, Hercules, CA). 
Measurement  of SRE and APrbinding  Activities  by  Gel-shift  Assay. 
SRE and AP  1 nucleotide consensus sequences were used in a gel-shift as- 
say essentially as described elsewhere (Bhat et ai., 1994). 3 pmol of either 
SRE or AP1 oligonucleotides were first labeled with [T-32p]ATP at 5' end 
by 10-rain incubation at 37°C with 4 U  of T4-polynucleotide kinase in 
10 ixl solution containing 70 mM Tris-HC1,  pH 7.6, 10 mM MgCh, 5 mM 
D'IT, and 10 IxCi [T-32p]ATP. The reaction was stopped by the addition of 
1 Ixl 0.5 M EDTA, and the volume was expanded to 100 p.l with 1× gel- 
shift assay buffer. 3ZP-labeled oligonucleotides (0.1 p,  Ci) were mixed with 
either 5 Ixg nuclear extract protein (for both SRE and AP  1 analysis) or 25 I~g 
cytoplasmic extract protein (for AP  1 analysis) containing 1 ×  gel-shift as- 
say buffer, 100 ng salmon sperm DNA, 2  ~g DNA duplex poly(dl-dC), 
and 10 I~g BSA in a final volume of 10 Ixl. The mixture was incubated at 
room temperature for 15 min and eleetrophoresed on a 5% PAGE in 
20 mM Tris-acetate buffer containing 5 nM EDTA, pH 8.0, for 90 min at a 
constant 200 V. Gel was decasted, wrapped in a plastic bag, and exposed 
to x-ray film overnight at -70°C (Lu et al., 1996). Films were processed 
and analyzed by an Imagestore System (Ultra Violet Products, Ltd., San 
Gabriel, CA). The densities of shifted bands on the gel representing the 
oligonucleotide-protein complexes were quantitated by the SW5000  Gel 
Analysis program and the data are presented as absorbance derived from 
the image analysis program (Lu et al., 1996). 
Double Fluorescence Staining of AT1 Receptor with NET mRNA and TH 
mRNA and TH with NET mRNA in Neuronal Cultures. RT  in  situ  PCR 
was combined with immunocytochemistry to determine the colocalization 
of the AT1 receptor with NET and TH mRNAs and TH with NET mRNA 
essentially as described previously (Lu and Raizada, 1995; Lu et al., 1996). 
Briefly, neuronal cells were fixed in neutral-buffered 1%  formalin, di- 
gested with trypsin and RNase-free DNase, and subjected to reverse tran- 
scriptase reactions with the use of specific primers for either NET or TH 
mRNA essentially as described previously (Lu et al., 1996).  Cells were 
washed, ethanol-dehydrated, and  an  eight-cycle in  situ  PCR  was  per- 
formed at 94°C/45 s, 60°C/45 s, and 73°C/1 min for each cycle. Cells were 
rinsed with PBS, pH 7.4, and incubated for i h with either anti-AT1 recep- 
tor or anti-TH monoclonal mouse antibodies, followed by incubation with 
10 p.g/ml FITC-conjugated anti-mouse IgG Fab fragments for 1 h at 37°C. 
Cells were washed in PBS, and the dual stainings of rhodamine-labeled 
NET mRNA or TH mRNA and FITC-labeled AT1 receptor or TH were 
analyzed and collected by confocal microscope as described above. 
Quantitation of c-los mRNA by RT-PCR. The protocol for quantitation 
of c-fos mRNA by RT-PCR was essentially as described previously (Lu 
and Raizada, 1995; Lu et al., 1995). 
Confocai Microscopic Analysis of Fluorescent Images of Neuronal Cells. 
Fluorescent-stained cells were dehydrated by ethanol and mounted in me- 
thylsalicylate and coverslipped. Samples were then examined under an in- 
verted microscope (BH-2; Olympus Corp., Lake Success, NY) that was in- 
terfaced to a  laser-scanning confocal system (MRC 600;  BioRad Labs) 
including a krypton/argon laser. Optical sections were collected at 1-1xm 
intervals and the images were Kalman-averaged. To present double stain- 
ing, the images were pseudocolored by the XV program (Silicon Graphics 
Incorporated, Sunnyville, CA) with green for FITC and red for rhoda- 
mine (Sumners et al., 1991). 
Experimental Groups and Data Analysis. Each  data  point  in  the  mea- 
surements of MAP kinase activity, nuclear MAP kinase contents, nuclear 
and cytoplasmic SRE or AP  1 gel-shift activities, and c-fos mRNA was ob- 
tained from three culture dishes, and each experiment was repeated three 
times. Data presented are mean -+ SE. Comparisons between data points 
were made by using one-way analysis of variance and Dunnett's test from 
the Statistica software (Statistiea Inc. Orlando, FL). All immunofluores- 
cent experiments were repeated at least six times; 100-250 cells were ex- 
amined and representative images were collected. 
Results 
Effects orAng H on MAP Kinase in Neuronal Cultures 
Incubation  of  neuronal  cultures  with  100  nM  Ang  II 
caused a time-dependent stimulation of MAP kinase activ- 
ity. The increase was significant as early as 5 min, reached 
maximal levels of approximately fourfold in  15 min, fol- 
Figure 1.  Effect of Ang II on MAP  kinase activity in neuronal 
cultures. Neuronal  cultures were incubated without (C) or with 
100 nM Ang II for the indicated time periods. This was followed 
by the measurement of MAP  kinase activity by in-gel assay es- 
sentially as described in Methods. (Top) A  representative autora- 
diogram. (Bottom) Mean -+ SE (n =  3). (*) Significantly different 
from control (P <  0.05). 
lowed by a significant decline in 30 min (Fig. 1). The stim- 
ulation was mediated by the AT1 receptor subtype since it 
was  completely blocked by  10  IxM losartan  but  not  by 
PD123319, an AT  2 receptor subtype antagonist. A  repre- 
sentative  double-staining  pattern  depicting  the  distribu- 
tion of MAP kinase immunoreactivity in relation to neu- 
rofilament immunoreactivity in the neuron is shown in Fig. 2. 
Staining for neurofilaments was  diffused and distributed 
throughout the cytoplasmic compartment of the neuronal 
soma (green). Significant staining was also seen in the neu- 
rites. In contrast, the same neuron, when stained for MAP 
kinase immunoreactivity, depicted a  discrete distribution 
of this enzyme (red).  MAP kinase immunoreactivity was 
predominantly localized around  the  nucleus,  although a 
little  staining  was  seen distributed throughout the  cyto- 
plasmic compartment of the cell soma. A combined image 
for the same cell depicting green, red, and yellow confirms 
the perinuclear stainings  of MAP kinase in the neuron. 
The unique staining of MAP kinase  around the nucleus 
was  characteristic for neuronal cells in  primary culture, 
since astroglial cells prepared from the same brains did not 
show such staining. In these cells, MAP kinase immunore- 
activity was diffused throughout the cytoplasmic compart- 
ment of the cell. In addition, vascular smooth muscle cells 
in culture showed diffused staining of this enzyme (data 
not shown). The perinuclear staining of MAP kinase was 
not an artifact of experimental protocol since many other 
combinations of fixation and staining showed similar dis- 
tribution. Finally, this pattern of staining in neurons was 
further confirmed by the use of another MAP kinase anti- 
body (Santa  Cruz,  Inc., Santa  Cruz,  CA).  Treatment of 
neuronal cultures with Ang II caused a dramatic redistri- 
bution of MAP kinase immunoreactivity (Fig. 3). After 5 
min  of incubation with Ang II,  the MAP kinase  immu- 
noreactivity that was distributed around the nucleus began 
to show a patchy appearance. In addition, the staining also 
Lu et al. MAP Kinase-mediated Signaling of  AT1 Receptor  1611 Figure 2.  Colocalization of neurofilaments and MAP kinase in neuronal cultures with the use of double immunofluorescent staining. 
Neuronal cultures were fixed and subjected to double staining with the use of specific antibodies to neurofilaments and MAP kinase es- 
sentially as described in Methods. Fluorescent images containing neurofilaments (green), MAP kinase (red), and a combination of neu- 
rofilaments and MAP kinase (yellow) were analyzed with the use of a confocal microscope. 
began to appear inside the nucleus. By 15 min, the major- 
ity of the immunoreactivity that had been present in the 
cytoplasmic compartment  was  translocated  into  the  nu- 
cleus. The translocated staining for MAP kinase in the nu- 
cleus displayed a patchy and aggregate appearance. These 
aggregates began  to  disappear  by 30 min of incubation 
with Ang II at which time a uniform, even distribution of 
MAP kinase  immunoreactivity was  observed  in  the  nu- 
cleus (Fig. 3). These immunocytochemical observations sug- 
gested that Ang II stimulates the translocation of MAP ki- 
nase  from the  perinuclear  region to  within  the  nucleus. 
This translocation was completely blocked by 10 ~M losar- 
tan  but  not  by PD123319,  indicating  that  AT1  receptor 
subtypes are involved in Ang II stimulation of MAP ki- 
nase translocation. 
Immunoblot analysis was carried out essentially as de- 
scribed previously (Yang et al., 1996) to confirm such a nu- 
clear  translocation of MAP kinase  by Ang II. Neuronal 
cultures were treated with 100 nM Ang II in the presence 
or absence of either losartan or PD123319 for 30 min, the 
nuclei were isolated, and the nuclear extracts were used to 
immunoprecipitate  MAP  kinase,  followed  by  immuno- 
blotting. Fig. 4 A shows that very little phosphorylated p42 
or p44 protein (two major forms of phosphorylated MAP 
kinase) was present in the nuclear fraction of control neu- 
ronal cultures.  Ang II caused an approximately fourfold 
increase  in  both phosphorylated p42  and  p44.  Losartan 
treatment (but not PD123319) blocked Ang II stimulation 
of the levels of both phosphorylated p42 and p44. MAP ki- 
nase translocated into the nucleus showed enzyme activity 
as determined by an in-gel assay. Fig. 4 B  shows that the 
levels of MAP kinase activity increased as a  function of 
time in the nuclear fraction with a maximal increase of six- 
fold in 15 min. 
Figure 3.  Effect of Ang II on redistribution of MAP kinase immunoreactivity in neuronal cultures. Neuronal cultures were incubated 
with 100 nM Ang II for the indicated time periods. Images represent two cells at each time point and are representative of six separate 
experiments in which a total of ,'~100 cells were observed. 
The Journal of Cell Biology, Volume 135, 1996  1612 Figure 4.  (A) Effects of losartan and PD123319 on Ang II-stimulated translocation of MAP kinase into the nucleus.  Neuronal cultures 
were incubated without (C) or with 100 nM Ang II for 30 min in the absence or presence of 10 IxM losartan (Los) or PD123319 (PD). 
Nuclear extracts  were prepared and MAP kinase was precipitated by incubating the extracts with anti-MAP kinase antibody conjugated 
to agarose followed by immunoblotting as described in Methods. (Top) A  representative  autoradiogram. (Bottom) Quantitation of 
bands corresponding to phosphorylated p42 and p44. (two major forms of phosphorylated MAP kinases) was carried out essentially  as 
described previously (Yang et al., 1996). Data are presented as mean ± SE (n = 3) for phosphorylated p42 ([2) and p44 (11). (*) Signifi- 
cantly (P <  0.05) different from control (C). (**) Significantly  (P <  0.05) different from Ang II-treated cells. (B) Effect of Ang II on 
MAP kinase activity in the nuclear fractions of neuronal cultures. Nuclear fractions were isolated from Ang II-treated neuronal cul- 
tures. MAP kinase activity was determined by in-gel assay essentially as described in Methods. (Top) Representative autoradiogram. 
(Bottom) Quantitation of a representative band corresponding to MAP kinase activity. Data are mean ± SE (n = 3). (*) Significantly dif- 
ferent (P < 0.05) from zero time. 
Mechanism of  Ang H Stimulation of Neuromodulation: 
Involvement of MAP Kinase 
Our previous studies have demonstrated that chronic incu- 
bation of neurons by Ang II causes a persistent increase in 
tyrosine hydroxylase activity and norepinephrine  uptake, 
effects associated with increased gene expression  for TH 
and NET (Lu et al.,  1996; Yu et al., 1996). We have used 
Ang II's ability to stimulate both these activities as a mea- 
sure  of the  neuromodulatory  actions  of this  hormone  in 
the  neurons.  Based  on  these  (Lu  et  al.,  1996;  Yu et  al., 
1996) and other observations  (Yang et al.,  1996), we had 
hypothesized that the activation of MAP kinase by Ang II 
results in its translocation into the nucleus, where it medi- 
ates  the  activation  of transcription  factor(s)  relevant  to 
stimulation of c-fos transcription.  This involves activation 
of SRE in the c-fos promotor. It leads to the activation of 
AP1  sites  on  the  promotor  region  of the  TH  and  NET 
genes to stimulate  the transcriptions of these genes. Thus, 
our next objective was to test this hypothesis by studying 
the effects of Ang II on SRE-binding activity and on Fos, 
two key players in this pathway. 
Incubation of neuronal cultures with Ang II resulted in 
a  time-dependent  stimulation  of SRE-binding  activity as 
measured by the gel-shift assay (Fig. 5).  A  stimulation of 
approximately twofold was observed as early as 5 min and 
reached maximal levels of eightfold in 15 min. The effect 
of MAP kinase AON on Ang II stimulation of SRE-bind- 
ing activity was determined to confirm the role of MAP ki- 
nase in this process. Neuronal cultures were preincubated 
with 1 }xM AON or SON for MAP kinase for 24 h  as de- 
scribed  previously  (Yang  et  al.,  1996).  This  treatment 
causes a ,--~70% decrease in both p42 and p44 isoforms of 
MAP kinase and causes a significant attenuation of Ang II 
stimulation  of TH  and  NET mRNA  levels  (Yang  et  al., 
1996). In addition, MAP kinase AON caused a significant 
decrease  in MAP kinase  immunostaining  (Fig.  6).  Fig.  7 
shows that  pretreatment  of neuronal  cultures  with  MAP 
kinase AON resulted in a significant attenuation of Ang II 
Figure 5.  Effect of Ang II on SRE-binding activity in nuclear ex- 
tracts of neurons. Neuronal cultures were incubated with 100 nM 
Ang II for the indicated time periods. Nuclear extracts were iso- 
lated  and  incubated  with  the  SRE-consensus oligonucleotide 
sequence. Binding of the oligonucleotides was determined by gel- 
shift assay essentially as described in Methods. (Top) A represen- 
tative  autoradiogram. (Bottom) A  band corresponding to SRE 
oligonucleotide-protein complex was quantitated from three sep- 
arate experiments and the data are presented as mean ± SE (n = 
3). (*) Significantly  different (P <  0.05) from zero time. 
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munostaining  of MAP kinase 
by MAP kinase antisense oli- 
gonucleotide.  Neuronal  cul- 
tures were incubated without 
(A) or with 1.0 I~M MAP ki- 
nase AON (B) or with MAP 
kinase  SON (C) for 24 h  at 
37°C.  Cells  were  fixed  and 
subjected  to immunostaining 
for MAP kinase as described 
in Methods. 
stimulation of SRE-binding activity. In contrast, SON for 
the  enzyme did  not  inhibit  Ang  II stimulation  of SRE- 
binding activity. 
Next, we studied the effect of Ang II on APl-binding ac- 
tivity, fos gene expression, and the involvement of MAP 
kinase in this process. The rationale for this was based on 
our previous observations that have established that Ang 
II stimulates c-fos gene expression in neurons and that in- 
tervention in  this  stimulation by c-fos antisense  oligonu- 
cleotide attenuates Ang II's stimulatory actions on NET 
and TH genes (Lu et al., 1996; Yu et al., 1996). Cytosolic 
and  nuclear  fractions  from  control  and  Ang  II-treated 
neuronal  cultures  were  prepared  and  the  levels of AP1- 
binding activity were quantitated. Fig. 8 shows a transient 
time-dependent increase in APl-binding activity in the cy- 
tosolic fraction. APl-binding activity was low in the cytosol 
of control neuronal cells. It increased with time, reaching a 
maximal level of ll-fold in 15 min followed by a significant 
decrease in  30 rain.  In contrast to the  cytosolic fraction, 
the increase of APl-binding activity in the nuclear fraction 
showed a  lag of ,-~5 min, followed by its time-dependent 
increase, reaching a  maximal stimulation of 10-fold in 30 
min. At this point, the level of nuclear APl-binding activ- 
ity was approximately twofold higher than the cytoplasmic 
level. MAP  kinase  AON was used  to  determine  the  in- 
volvement of this enzyme in Ang II stimulation of AP1- 
binding activity. After preincubation of neuronal cultures 
for 24 h with MAP kinase AON or SON, cells were incu- 
bated with  100  nM  Ang II and  whole-cell extracts were 
used  for  the  determination  of APl-binding  activity  and 
Fos-mRNA levels. Ang II stimulation of APl-binding ac- 
tivity was inhibited by 80% by MAP kinase AON and not 
by SON (Fig. 9).  In addition,  treatment of neuronal cul- 
tures with MAP kinase AON resulted in the attenuation 
of Ang II stimulation of c-fos mRNA levels (Fig. 10). 
Finally, we addressed the issue of the relative localiza- 
tion of various components of the Ang II effector system 
in our neuronal cultures. Our hypothesis that Ang II stim- 
ulation of NET and TH genes involves MAP kinase, SRE, 
and Fos assumes that these events are occurring in a single 
neuron and that there is no interneuronal flow of signaling 
molecules. Since neuronal cultures are prepared from the 
hypothalamic-brainstem  areas  and  contain  functionally 
diverse neurons, it was imperative to demonstrate colocal- 
ization  of these  components  to  validate  this  hypothesis. 
Fig. 11 shows a series of images from immunocytochemical 
staining in combination with in situ RT-PCR that suggests 
that the components of the Ang II effector system are lo- 
calized in one neuron. With the use of two separate AT1 
receptor  antibodies  we  found  that  AT1  receptor  immu- 
noreactivity (green) was colocalized with neurons contain- 
ing Fos, NET mRNA, and TH mRNA.  In addition,  the 
TH immunoreactivity was colocalized with the NET mRNA 
in Ang II-treated cultures.  These data indicate that AT  1 
receptors are localized on noradrenergic neurons that con- 
tain essential components of the Ang II signaling pathways 
responsible for this hormone's neuromodulatory actions. 
Figure 11.  Colocalization  of AT1 receptors with Fos immunoreactivity, NET and TH messenger RNAs, and TH immunoreactivity with 
NET mRNA in Ang II-treated neurons. Neuronal cultures were treated with 100 nM Ang II for 20 min at 37°C for colocalization of AT 1 
receptor with Fos immunoreactivity (ATI+Fos), and 2 h for AT1 receptor and NET mRNA (ATI+NET), AT1 receptor and TH 
mRNA (ATI+TH), and TH immunoreactivity and NET mRNA (TH+NET). Cultures  were fixed and used for colocalization  essen- 
tially as described  in Methods.  Red represented Fos immunoreactivity,  NET mRNA, and TH mRNA, and green represented AT1 re- 
ceptor and TH immunoreactivities.  Yellow represented colocalization of the two stainings. Images are representative from six separate 
experiments where ,-~80 cells were observed for each colocalization analysis. 
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Ang II stimulation  of SRE-binding  activity in neurons.  Neuronal 
cultures were preincubated  with 1 ~M AON or SON for MAP ki- 
nase for 24 h at 37°C. This was followed by incubation with 100 nM 
Ang II for 30 min at 37°C. Nuclei were isolated and lysed, and nu- 
clear extracts were used to carry out gel-shift analysis for the de- 
termination of SRE-binding activity  essentially  as described  in 
Methods.  (Top) A representative  autoradiogram.  (Bottom) Mean 
+- SE (n = 3). (*) Significantly different  (P <  0.05) from control 
(C). (**) Significantly different (P <  0.05) from Ang II-treated 
ceils. 
Figure 8.  Distribution of APl-binding activity in cytoplasmic and 
nuclear fractions  of Ang II-treated neurons.  Neuronal cultures 
were treated with 100 nM Ang II for the indicated  time periods. 
Cytoplasmic  ([2)  and nuclear  (11) extracts were prepared and 
subjected  to gel-shift  analysis  to determine the  levels  of APr 
binding activity essentially as described  in Methods.  (Top) Rep- 
resentative autoradiograms for cytoplasmic and nuclear fractions. 
(Bottom) Mean ± SE (n = 3) of the band corresponding to APt 
oligonucleotide-protein complex. (*) Significantly different (P < 
0.05) from zero time. 
Discussion 
The observations presented in this study are the first dem- 
onstration that MAP kinase immunoreactivity is primarily 
localized  around  the  nucleus  and  that  its  activation  and 
translocation into the nucleus by Ang II are key regulatory 
events in this hormone's neuromodulatory actions in neu- 
rons. In addition, a  sequence of signaling events involved 
in the Ang II stimulation of TH and NET genes has been 
described  based  on  experimental  data  presented  in  this 
study and elsewhere (Yang et al., 1996). 
AT1  receptors are distributed  rather uniformly on the 
neuronal plasma membrane. Within  5  min of incubation 
with Ang II, they undergo redistribution and become asso- 
ciated with Ras (Yang et al., 1996). This interaction is tran- 
sient and results in the activation of Ras followed by the 
interaction of Ras with Raf-1 that ultimately leads to the 
activation of Raf-1  (Yang et al.,  1996).  These  events in- 
volving the AT1 receptor, Ras, and Raf-1 have been sug- 
gested to occur on the plasma membrane of the neurons, 
and  are  important in  the  Ang II-mediated activation of 
MAP kinase.  Activation of MAP kinase is accompanied 
by its translocation into the nucleus in 15 min. The translo- 
cated enzyme is the active form of the MAP kinase as evi- 
denced by the presence of the phosphorylated p42 and p44 
isoforms in the nuclear extracts of Ang II-treated neurons. 
In  addition,  nuclear  enzymes  possess  kinase  activity  as 
shown by the in-gel assay (Fig. 4  B).  The activation and 
translocation of MAP kinase subsequently participate in 
the  Ang  II-mediated activation of SRE-binding  activity 
and c-fos gene expression, and APl-binding activity. Evi- 
dence for this conclusion is derived from the observations 
that show that the Ang II-mediated stimulation of SRE- 
binding  activity, c-fos gene  expression,  and  APrbinding 
activity are attenuated  by the preincubation  of neuronal 
cells with AON for MAP kinase. These observations dem- 
onstrate that translocation of MAP kinase into the nucleus 
may be required  for the  Ang  II-mediated activation  of 
SRE-binding  activity,  c-fos  gene  expression,  and  APt 
binding activity in the neurons. This is consistent with the 
proposed role of this enzyme in other systems (Gonzalez 
et al., 1993;  Khalil and Morgan, 1993;  Ward et al., 1994). 
Our  data  also  suggest  the  hypothesis  that  activation  of 
these transcription factors by Ang II results in their bind- 
ing to the APl-binding site on the promotor regions of TH 
and NET genes to stimulate their transcription.  There is 
sufficient  evidence  to  support  this  hypothesis:  (a)  APt 
binding activity is increased in neurons treated with Ang 
II. (b) APl-binding sites, which are Ang II responsive, are 
demonstrated in the promotor region of at least one of the 
genes (TH) (Goc and Stachoviak, 1994).  (c) MAP kinase 
stimulates  activation of various transcription  factors,  in- 
cluding Fos (this study) and Jun, which have been shown 
to interact with the APl-binding site (Beato, 1991; Puri et al., 
1995). The fact that Ang II stimulates c-fos and that c-fos 
stimulation  is important for Ang II stimulation  of NET 
and TH genes further supports this hypothesis (Lu et al., 
1996; Yu et al., 1996). 
There  are  two  unique  features  of these  observations. 
First, MAP kinase immunoreactivity is primarily localized 
around the nucleus with little distribution in the cytoplas- 
mic  compartment  in  the  neurons.  This  distribution  is 
unique  to  neurons  since  other  studies  have  shown  that 
MAP kinase is diffusely distributed throughout the cyto- 
Lu et al. MAP Kinase-mediated Signaling of  ATt Receptor  1615 Figure 9.  Effect of MAP  kinase  antisense  oligonucleotide  on 
Ang II stimulation  of APFbinding activity in the neurons.  Neu- 
ronal cultures were preincubated with 1.0 ixM MAP kinase AON 
or SON for 24 h at 37°C. Whole cell lysates were prepared and 
used for gel-shift analysis for the quantitation of APt-binding  ac- 
tivity essentially as described in Methods. (Top) A representative 
autoradiogram. (Bottom) Mean -+ SE (n  =  3). (*) Significantly 
different (P < 0.05) from control (C). (**) Significantly different 
(P < 0.05) from Ang II-treated cells. 
Figure 10.  Effect of MAP kinase  antisense  oligonucleotide  on 
Ang II stimulation  of c-fos mRNA in the neurons.  Neuronal cul- 
tures were pretreated with 1.0 I~M MAP kinase AON or SON for 
24 h at 37°C. Poly(A÷)RNA was isolated  after treatment of cul- 
tures with 100 nM Ang II for 20 min at 37°C. RT-PCR was car- 
ried out with the use of specific c-fos primers essentially  as de- 
scribed  in  Methods.  (Top)  A  representative  autoradiogram. 
(Bottom) Mean -+ SE of the band in the PCR representing c-fos 
mRNA. (*) Significantly different (P <  0.05) form control (C). 
(**) Significantly different (P < 0.05) from Ang II-treated cells. 
plasmic compartment in other cell types (Khalil and Mor- 
gan, 1993; Lamy et al., 1993; Zhao et al., 1995).  Thus, it is 
tempting to suggest that MAP kinase may be anchored to 
the nuclear membrane in neurons. This view is supported 
by studies  demonstrating the  anchoring of other protein 
kinases to the  cytoskeletal and  other membranes by an- 
choring proteins (Mochly-Rosen, 1994). Additional exper- 
iments would be needed  to confirm this  conclusion.  The 
relevance of such a localization of MAP kinase and its role 
in AT1 receptor-mediated signaling mechanism is not evi- 
dent at the present time. However, it may be possible that 
the enzyme could be responsible for the phosphorylation 
of specific protein(s) that may participate in the transloca- 
tion of MAP kinase and other proteins into the nucleus. 
This view is supported by many observations in the litera- 
ture  demonstrating  the  phosphorylation  of  proteins  lo- 
cated on the nuclear membrane by other kinases that are 
involved in their transport across the nuclear membrane 
(Hennekes et al., 1993; Murray et al., 1994).  For example, 
protein kinase C-mediated phosphorylation of lamin B  is 
associated with its transport across the nuclear membrane 
(Hennekes  et  al.,  1993;  Murray  et  al.,  1994).  Consistent 
with  this  is  our  data  showing  that  MAP  kinase  AON 
blocks transport of STAT-3 into the nucleus (Raizada, K., 
H. Yang, and D. Lu, unpublished observation). 
The second unique feature of these findings is the dem- 
onstration that MAP kinase is involved in the regulation 
of TH and NET, two genes whose products are key players 
in  the  synthesis, turnover, and metabolism of CA. Thus, 
those  neuromodulatory  actions  of  Ang  II  that  involve 
norepinephrine turnover, synthesis, and release (Raizada 
et  al.,  1994;  Sumners  et  al.,  1985,  1987;  Sumners  and 
Raizada, 1986) are mediated by the activation of MAP ki- 
nase.  Although  the  involvement  of  this  enzyme  in  the 
growth promoting and other actions of various hormones, 
including  Ang II, has been well documented (Sadoshima 
et al., 1995; Yamazaki et al., 1995), its role in neuromodu- 
lation in terminally differentiated neurons in primary cul- 
ture  is  a  new  observation.  In  fact,  the  participation  of 
MAP kinase in the neuromodulatory actions of Ang II is 
highly specific since the neurotrophic actions that involve 
plasminogen activator inhibitor-1  do not involve this en- 
zyme. This conclusion is based on our previous observa- 
tions  indicating  that  MAP  kinase  AON  failed  to  block 
Ang II stimulation of PAI-1 mRNA in neuronal cultures, 
whereas it abolished the stimulation of TH and NET mRNA 
levels by Ang II (Wright and Harding, 1994). 
In summary, these observations provide evidence for a 
sequence of signal transduction events initiated by the in- 
teraction of Ang II with the  AT  1 receptor and involving 
the  activation and  translocation  of MAP kinase into  the 
nucleus. These events are key in transcriptional control of 
CA-relevant genes and thus in chronic stimulation of CA 
turnover in neurons. However, many questions remain, in- 
cluding:  (a) How does activation of MAP kinase partici- 
pate in the transport of signaling molecules across nuclear 
membrane activated; (b) how does Raf-1 participate in the 
activation  of MAP  kinase  since  their  distribution  is  far 
apart in the cells; and (c) what is the nature of the anchor 
protein(s) for MAP kinase in the neurons? Future studies 
will attempt to answer these issues. 
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